Loading your page…
Each register with its number of medicines and a few of them.
Anvisa · 318 medicines
Health Canada · 161 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 78 medicines
SFDA · 52 medicines · Historical list
AEMPS · 30 medicines
AIFA · 14 medicines
HSA · 9 medicines
ALIMS · 8 medicines
TFDA · 8 medicines
CBG-MEB · 4 medicines
PHARMAC · 3 medicines
MS · 2 medicines · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
79 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Neomycin Sulfate | United States | 500MG | tablet | Marketed | Bristol Myers Squibb |
| Neomycin and Polymyxin B SulfateCombination | United States | 40MG BASE/ML; 200,000 UNITS/ML | solution | Marketed | Watson Labs |
| Neomycin and Polymyxin B Sulfates and GramicidinCombination | United States | 0.025MG/ML; 1.75MG BASE/ML; 10,000 UNITS/ML | solution/drops | Marketed | Watson Labs |
| Neomycin and Polymyxin B Sulfates and DexamethasoneCombination | United States | 0.1%; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Neomycin and Polymyxin B Sulfates and HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Marketed | Sandoz |
| Neomycin and Polymyxin B Sulfates and HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | solution/drops | Marketed | Amneal |
| Neomycin and Polymyxin B Sulfates and HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Marketed | Sciegen Pharms |
| Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and HydrocortisoneCombination | United States | 400 UNITS/GM; 1%; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Neomycin and Polymyxin B Sulfates and Bacitracin ZincCombination | United States | 400 UNITS/GM; 3.5MG BASE/GM; 10,000 UNITS/GM | ointment | Marketed | Bausch and Lomb INC |
| Neomycin Sulfate-Triamcinolone AcetonideCombination | United States | 3.5MG BASE/GM; 0.1% | ointment | Not marketed | Fougera |
| Neomycin Sulfate-Triamcinolone AcetonideCombination | United States | 3.5MG BASE/GM; 0.1% | cream | Not marketed | Pharmaderm |
| Neomycin Sulfate and Polymyxin B Sulfate GramicidinCombination | United States | 0.025MG/ML; 1.75MG BASE/ML; 10,000 UNITS/ML | solution/drops | Not marketed | Pharmafair |
| Neomycin Sulfate, Polymyxin B Sulfate & HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Not marketed | Pharmafair |
| Neomycin Sulfate-Polymyxin B Sulfate-HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Not marketed | Pharmafair |
| Neomycin Sulfate-Polymyxin B Sulfate-HydrocortisoneCombination | United States | 1%; 3.5MG BASE/ML; 10,000 UNITS/ML | solution/drops | Not marketed | Pharmafair |
| Neomycin Sulfate-Dexamethasone Sodium PhosphateCombination | United States | 0.1% PHOSPHATE; 3.5MG BASE/ML | solution/drops | Not marketed | Alcon Pharms LTD |
| Neomycin and Polymyxin B Sulfates and DexamethasoneCombination | United States | 0.1%; 3.5MG BASE/ML; 10,000 UNITS/ML | suspension/drops | Not marketed | Alcon Pharms LTD |
| Neomycin Sulfate and Dexamethasone Sodium PhosphateCombination | United States | 0.1% PHOSPHATE; 3.5MG BASE/ML | solution/drops | Not marketed | Bausch and Lomb |
| Neomycin & Polymyxin B Sulfates & Bacitracin Zinc & HydrocortisoneCombination | United States | 400 UNITS/GM; 1%; 3.5MG BASE/GM; 5,000 UNITS/GM | ointment | Not marketed | Pharmafair |
| Bacitracin-Neomycin-PolymyxinCombination | United States | 400 UNITS/GM; 3.5MG BASE/GM; 5,000 UNITS/GM | ointment | Not marketed | Pharmaderm |
| Neosporin G.U. IrrigantCombination | United States | 40MG BASE/ML; 200,000 UNITS/ML, 800MG BASE/20ML; 4,000,000 UNITS/20ML (EQ 40MG BASE/ML | solution | Marketed | Monarch Pharms |
| NeosporinCombination | United States | 3.5MG BASE/GM; 10,000 UNITS/GM | cream | Not marketed | Glaxosmithkline |
| Neo-Fradin | United States | 87.5MG BASE/5ML | solution | Not marketed | X Gen Pharms |
| Neo-RX | United States | 100% | powder | Not marketed | X Gen Pharms |
| Bacitracin Zinc-Neomycin Sulfate-Polymyxin B SulfateCombination | United States | 400 UNITS/GM; 3.5MG BASE/GM; 5,000 UNITS/GM | ointment | Not marketed | Naska |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
